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Significance and Impact of the Study: The spread of antimicrobial resistance among pathogenic bacteria
is an important problem, but the mechanisms of horizontal transfer between strains and species are
often poorly understood. For instance, little is known on how macrolide resistance spreads between
strains of the human pathogen Strep. pyogenes and why certain strains more commonly display resis-
tance than others. Here, we show that Strep. pyogenes strains vary greatly in their ability to acquire a
transposon encoding macrolide resistance by horizontal gene transfer in vitro. These data provide a
novel insight into the transfer of antibiotic resistance between bacterial strains and offer an explana-
tion for the differences in the frequency of resistance determinates and resistance seen among clinical
isolates.
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Abstract
The aim of this study was to examine the gene transfer potential of mef(A)-
containing Tn120.3 to macrolide-susceptible Streptococcus pyogenes belonging to
different emm types. Using the filter mating technique, Tn1207.3 was
transferred by conjugation to 23 macrolide-susceptible recipients representing
11 emm types. PCR analysis confirmed the presence of the mef(A) gene and the
comEC junction regions of the Tn1207.3 insertion in resultant transconjugants.
Significant variation was found in the transfer frequency of Tn1207.3 to
different Strep. pyogenes strains, and this phenomenon may contribute to the
differences in mef(A) frequency observed among clinical isolates.
Introduction
Streptococcus pyogenes (group A streptococci/GAS)
remains an important human pathogen responsible for a
wide variety of invasive and noninvasive infections
including pharyngotonsillitis, skin and soft tissue infec-
tions and bacteraemia. Macrolides are widely used to treat
GAS infections in patients allergic to b-lactam antibiotics.
The development and spread of macrolide resistance
among GAS throughout the world is therefore a major
concern.
The drug efflux pump, encoded by the mef gene (cur-
rently represented by four subclasses A, E, I and O), is
one of the most common mechanisms responsible for
resistance to 14- and 15-membered macrolides in GAS
and other species (Sutcliffe et al. 1996a; Varaldo et al.
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2009). At least three mobile elements carrying the mef(A)
gene have been identified in GAS: the Tn1207.3 transpo-
son (Santagati et al. 2003), the Φ10394.4 phage chimera
(Banks et al. 2003) and the Φm46.1 element (Brenciani
et al. 2010). Studies indicate a significant prevalence of
the mef(A) gene among GAS isolates in Europe and else-
where. For instance, nationwide surveillance in Germany
noted a frequency of 31% (Bley et al. 2011), while an Ital-
ian study found the prevalence of mef(A) among GAS to
be 16% (Creti et al. 2005). Interestingly, there appears to
be a skewed distribution of macrolide resistance genes
among different GAS strains belonging to different emm
types. The mef(A) gene is most frequently harboured by
certain emm types such as emm1, emm2, emm3, emm4,
emm9, emm12 and emm75, whereas emm types such as
emm22, emm77, emm87 and emm89 have not yet been
documented to carry any mef determinant (Creti et al.
2005; Grivea et al. 2006; Silva-Costa et al. 2008; Wajima
et al. 2013). These observations suggest differences in the
capacity of GAS emm types to acquire mef genes, and
while the horizontal gene transfer of mef(A)-bearing
genetic elements has been demonstrated in vitro by conju-
gation (Giovanetti et al. 2003; Santagati et al. 2003) and
by transduction (Di Luca et al. 2010), no comparison has
yet been made of mef gene transfer frequencies among
different GAS strains.
The aim of this study therefore was to examine the
transfer frequency of mef(A)-containing Tn1207.3 to
diverse macrolide-susceptible recipients representing a
variety of clinically important emm types.
Results and discussion
Erythromycin-resistant transconjugants were detected in
21/23 of the tested recipient strains, with mean frequen-
cies of transconjugants ranging from 720 9 108 to
113 9 106 conjugant/recipient (Table 1). Statistical
analysis showed that there was a significant difference in
the conjugation frequency between strains (ANOVA,
P < 0001). PCR confirmed that all 85 randomly selected
transconjugants were positive for the mef(A) gene as well
as the 5′ and 3′ junctions of Tn1207.3-comEC. All ampli-
cons were of the expected size. Thus, growth on erythro-
mycin-selective plates can be taken as being strongly
indicative of mef(A) acquisition by the previously suscep-
tible, mefA-negative recipient strains and the integration
of Tn1207.3 into the comEC locus.
The association of emm type with conjugative fre-
quency is difficult to assess given the number of isolates
of each emm type was low. However, the data show a
trend for higher frequencies of conjugation among emm1
and emm4, seen in the region of 106 to 107 with lower
Table 1 Strain characteristics and gene transfer frequencies of the mef(A)-bearing Tn1207.3 element (SMH036) to macrolide-susceptible
Strep. pyogenes
emm type Recipient Multilocus sequence type Site of isolation
Mean frequencies of three
transfers per recipient  SEM
emm1 R366 ST28 Blood 983 9 106  187 9 106
R203 ST28 Blood 113 9 106  646 9 107
R057 ST28 Eye 386 9 106  191 9 106
R502 Not available Blood 423 9 106  185 9 106
emm2 R837 ST55 Blood 317 9 106  352 9 107
R007 ST55 Blood 237 9 106  530 9 107
emm3 R032 ST315 Throat 120 9 107  152 9 108
R079 ST315 Throat 980 9 107  172 9 107
emm4 R317 ST39 Blood 450 9 107  493 9 108
R211 ST39 Blood 647 9 107  105 9 107
R101 ST39 Ear 617 9 106  375 9 107
emm9 R480 ST75 Blood 920 9 107  189 9 107
R097 ST75 Pus 160 9 107  153 9 108
emm11 R098 ST22 Blood 813 9 107  167 9 107
R693 ST22 Blood 367 9 107  186 9 108
emm12 R214 ST36 Blood 119 9 107  501 9 108
R113 ST36 Throat 397 9 107  497 9 108
R044 ST36 Throat 600 9 107  888 9 108
emm59 R205 Not available Blood 436 9 108  860 9 109
emm77 R054 ST77 Skin <377 9 108 (none detected)
R115 ST77 Vagina <108 9 108 (none detected)
emm81 R202 ST117 Blood 397 9 107  148 9 107
emm87 R208 ST62 Blood 720 9 108  899 9 109
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rates seen particularly with the single isolates of emm59
and emm87, in the region of 109, Table 1. These pat-
terns correlate well with the observed frequency of mef(A)
among clinical isolates belonging to these emm types, mef
(A) being highly prevalent among emm1 and emm4 iso-
lates but having not been reported among emm59 and
emm87 isolates (Creti et al. 2005; Grivea et al. 2006;
Silva-Costa et al. 2008; Wajima et al. 2013). These data
also highlight the potential for the emergence of mef
(A)-mediated resistance in previously susceptible emm
types. Two isolates, both belonging to emm77, did not
produce transconjugants above the lower limit of detec-
tion, Table 1, suggesting that a low capacity for acquisi-
tion exists among emm77. This again correlates well with
epidemiological data, and emm77 has not previously been
associated with mef(A). Interestingly, previous work using
transduction also failed to transfer mefA into an emm 77
isolate (Di Luca et al. 2010). All seven emm types
included here and reported previously to harbour the mef
(A) gene were able to acquire it by conjugation in vitro.
Taking only the emm types for which at least three iso-
lates were included, emm1, emm4 and emm12, the higher
mean frequencies of transconjugants seen with emm1 and
emm4 isolates were statistically significant compared to
those seen with emm12 isolates. This suggests that an
association exists between emm type and the transfer fre-
quency of Tn1207.3 but the testing of a larger collection
of isolates is needed to explore this further.
Together the results demonstrate that significant vari-
ability exists in mef(A) gene conjugative transfer rates
between Strep. pyogenes strains and that this phenomenon
may contribute, at least in part, to the different frequen-
cies of mef(A) observed among clinical GAS strains. The
mechanisms responsible for these differing rates of mefA
transfer are not known, but M proteins have previously
been proposed to act as barriers for horizontal gene
exchange and thus may play a role (Schmitz et al. 2003).
Furthermore, we demonstrate potential for the develop-
ment of mef(A)-mediated erythromycin resistance in cur-
rently susceptible lineages.
Materials and methods
Bacterial isolates
Group A streptococci isolates were collected, as part of
a separate study, from two London Hospitals, St.
Mary’s and Paddington and Hammersmith, between
1993 and 2005 (McGregor and Spratt 2005). mef(A)
recipient strains belonged to the following eleven emm
types: emm1, emm2, emm3, emm4, emm9, emm11,
emm12, emm59, emm77, emm81 and emm89. Strains
were chosen based on their availability for study and
because they include some of the most common lin-
eages among clinical disease isolates in Europe (Steer
et al. 2009) (Table 1). They also include lineages with
observed differences in their frequency of mef(A) preva-
lence (Creti et al. 2005; Grivea et al. 2006; Silva-Costa
et al. 2008; Wajima et al. 2013). Isolate SMH036
(emm75) was used as the Tn1207.3 donor and carries
the Tn1207.3 element inserted into the comEC locus.
Discrimination of mef gene subclasses A, E, O and I by
RFLP analysis confirmed the presence of only mef(A) in
SMH036. SMH036 was confirmed to be resistant to
erythromycin with a MIC of 8 mg l1 and grew readily
on 2 mg l1 erythromycin-selective blood plates. It was,
however, susceptible to fusidic acid and rifampicin. All
recipient strains were confirmed to be susceptible to
erythromycin (MIC < 0015–012 g l1) and unable to
grow on selective blood agar plates containing 2 mg l1
erythromycin used in screening for transconjugants. The
wild-type recipients were also confirmed to be suscepti-
ble to rifampicin and fusidic acid, and resistant deriva-
tives of these, used to differentiate transconjugants from
SMH036, were generated by inducing to spontaneous
mutations conferring resistance to rifampicin or fusidic
acid.
In vitro conjugative gene transfer of Tn1207.3
Filter mating was performed according to Giovanetti et al.
(Giovanetti et al. 2002). Transconjugants were selected on
blood agar plates containing either fusidic acid (25 mg l1)
or rifampicin (25 mg l1) in addition to erythromycin
(2 mg l1). Transfers were performed in triplicate.
Confirmation of mef(A) transfer
Putative transconjugants were tested for the presence of
mef(A) by PCR using primers mefF/mefR as previously
described (Sutcliffe et al. 1996b). Both Tn1207.3/comEC
junctions were also examined by PCR, primers TnRjF/
TnRjR (D’Ercole et al. 2005) spanning the 5′ junction
and comECF/orfLF (Santagati et al. 2003) spanning the 3′
junction. Donor SMH036 was used as a positive control
for these PCRs. Transconjugants were randomly selected
(3–6 per donor/recipient combination) for PCR valida-
tion with a total of n = 85. All recipient strains produced
no amplicons in these PCRs.
Acknowledgements
The support of Dr. Karen F. McGregor (University of
West London) and the internal funding provided by the
University of West London are gratefully acknowledged.
EMH and GKP are supported by the MRC.
Letters in Applied Microbiology 58, 299--302 © 2014 The Authors published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology 301
N.F. Hadjirin et al. mef(A) transfer to GAS
Conflict of interest
No conflict of interest declared.
References
Banks, D.J., Porcella, S.F., Barbian, K.D., Martin, J.M. and
Musser, J.M. (2003) Structure and distribution of an
unusual chimeric genetic element encoding macrolide
resistance in phylogenetically diverse clones of group A
Streptococcus. J Infect Dis 188, 1898–1908.
Bley, C., Van Ded Linden, M. and Reinert, R.R. (2011) mef(A)
is the predominant macrolide resistance determinant in
Streptococcus pneumoniae and Streptococcus pyogenes in
Germany. Int J Antimicrob Agents 37, 425–431.
Brenciani, A., Bacciaglia, A., Vignaroli, C., Pugnaloni, A.,
Varaldo, P.E. and Giovanetti, E. (2010) Phi m46.1, the
main Streptococcus pyogenes element carrying mef(A) and
tet(O) genes. Antimicrob Agents Chemother 54, 221–229.
Creti, R., Gherardi, G., Imperi, M., Von Hunolstein, C.,
Baldassarri, L., Pataracchia, M., Alfarone, G., Cardona, F.
et al. (2005) Association of group A streptococcal emm
types with virulence traits and macrolide-resistance genes
is independent of the source of isolation. J Med Microbiol
54, 913–917.
D’Ercole, S., Peterelli, D., Prenna, M., Zampaloni, C., Catania,
M.R., Ripa, S. and Vitali, L.A. (2005) Distribution of mef
(A)-containing genetic elements in erythromycin-resistant
isolates of Streptococcus pyogenes from Italy. Clin Microbiol
Infect 11, 927–930.
Di Luca, M.C., D’ercole, S., Peterelli, D., Prenna, M., Ripa, S.
and Vitali, L.A. (2010) Lysogenic transfer of mef(A) and
tet(O) genes carried by phi m46.1 among group A
streptococci. Antimicrob Agents Chemother 54, 4464–4466.
Giovanetti, E., Brenciani, A., Burioni, R. and Varaldo, P.E.
(2002) A novel efflux system in inducibly erythromycin-
resistant strains of Streptococcus pyogenes. Antimicrob
Agents Chemother 46, 3750–3755.
Giovanetti, E., Brenciani, A., Lupidi, R., Roberts, M.C. and
Varaldo, P.E. (2003) Presence of the tet(O) gene in
erythromycin- and tetracycline-resistant strains of
Streptococcus pyogenes and linkage with either the mef(A)
or the erm(A) gene. Antimicrob Agents Chemother 47,
2844–2849.
Grivea, I.N., AL-Lahham, A., Katopodis, G.D.,
Syrogiannopoulos, G.A. and Reinert, R.R. (2006)
Resistance to erythromycin and telithromycin in
Streptococcus pyogenes isolates obtained between 1999 and
2002 from Greek children with tonsillopharyngitis:
phenotypic and genotypic analysis. Antimicrob Agents
Chemother 50, 256–261.
McGregor, K.F. and Spratt, B.G. (2005) Identity and
prevalence of multilocus sequence typing-defined clones of
group A streptococci within a hospital setting. J Clin
Microbiol 43, 1963–1967.
Santagati, M., Iannelli, F., Cascone, C., Campanile, F., Oggioni,
M.R., Stefani, S. and Pozziz, G. (2003) The novel
conjugative transposon Tn1207.3 carries the macrolide
efflux gene mef(A) in Streptococcus pyogenes. Microb Drug
Resist 9, 243–247.
Schmitz, F.J., Beyer, A., Charpentier, E., Normark, B.H.,
Schade, M., Fluit, A.C., Hafner, D. and Novak, R. (2003)
Toxin-gene profile heterogeneity among endemic invasive
European group A streptococcal isolates. J Infect Dis 188,
1578–1586.
Silva-Costa, C., Pinto, F.R., Ramirez, M., Melo-Cristino, J. and
Portuguese Surveillance Group (2008) Decrease in
macrolide resistance and clonal instability among
Streptococcus pyogenes in Portugal. Clin Microbiol Infect 14,
1152–1159.
Steer, A.C., Law, I., Matatolu, L., Beall, B.W. and Carapetis,
J.R. (2009) Global emm type distribution of group A
streptococci: systematic review and implications for
vaccine development. Lancet Infect Dis 9, 611–616.
Sutcliffe, J., Tait-Kamradt, A. and Wondrack, L. (1996a)
Streptococcus pneumoniae and Streptococcus pyogenes
resistant to macrolides but sensitive to clindamycin: a
common resistance pattern mediated by an efflux system.
Antimicrob Agents Chemother 40, 1817–1824.
Sutcliffe, J., Grebe, T., Tait-Kamradt, A. and Wondrack, L.
(1996b) Detection of erythromycin-resistant determinants
by PCR. Antimicrob Agents Chemother 40, 2562–2566.
Varaldo, P.E., Montanari, M.P. and Giovanetti, E. (2009)
Genetic elements responsible for erythromycin resistance
in streptococci. Antimicrob Agents Chemother 53, 343–353.
Wajima, T., Morozumi, M., Chiba, N., Shouji, M., Iwata, S.,
Sakata, H. and Ubukata, K. (2013) Associations of
macrolide and fluoroquinolone resistance with molecular
typing in Streptococcus pyogenes from invasive infections,
2010–2012. Int J Antimicrob Agents 42, 447–449.
Letters in Applied Microbiology 58, 299--302 © 2014 The Authors published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology302
mef(A) transfer to GAS N.F. Hadjirin et al.
